Financials
Reported figures only · latest: Q4 2024
DKK · IFRS
Source: SEC XBRL filings
· latest filing
The long view
Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income10 fiscal yearsShow the numbers
| Year | Revenue | Net income |
|---|
| FY25 | - | - |
|---|
| FY24 | DKK 21.5B | DKK 7.8B |
|---|
| FY23 | DKK 16.5B | DKK 4.4B |
|---|
| FY22 | DKK 14.5B | DKK 5.5B |
|---|
| FY21 | DKK 8.4B | DKK 3B |
|---|
| FY20 | DKK 10.1B | DKK 4.8B |
|---|
| FY19 | DKK 5.4B | DKK 2.2B |
|---|
| FY18 | DKK 3B | DKK 1.5B |
|---|
| FY17 | DKK 2.4B | DKK 1.1B |
|---|
| FY16 | - | - |
|---|
MarginsShare of revenue- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|
| FY25 | - | - |
|---|
| FY24 | 31.1% | 36.4% |
|---|
| FY23 | 32.3% | 26.4% |
|---|
| FY22 | 43.2% | 37.6% |
|---|
| FY21 | 35.1% | 35.1% |
|---|
| FY20 | 62.4% | 47.1% |
|---|
| FY19 | 49.2% | 40.4% |
|---|
| FY18 | 45.6% | 48.7% |
|---|
| FY17 | 56.8% | 46.7% |
|---|
| FY16 | - | - |
|---|
Free cash flowOperating cash flow minus capital expenditureShow the numbers
| Year | Free cash flow |
|---|
| FY25 | - |
|---|
| FY24 | DKK 7.6B |
|---|
| FY23 | DKK 7B |
|---|
| FY22 | DKK 3.6B |
|---|
| FY21 | DKK 2B |
|---|
| FY20 | DKK 6.1B |
|---|
| FY19 | DKK 1.2B |
|---|
| FY18 | DKK 943M |
|---|
| FY17 | DKK 1.5B |
|---|
| FY16 | - |
|---|
Net margin vs the sectorMedian of Healthcare companies filing with the SECShow the numbers
| Year | Genmab | Healthcare median |
|---|
| FY25 | - | −30.6% |
|---|
| FY24 | 36.4% | −47% |
|---|
| FY23 | 26.4% | −58% |
|---|
| FY22 | 37.6% | −80.4% |
|---|
| FY21 | 35.1% | −71.9% |
|---|
| FY20 | 47.1% | −62.2% |
|---|
| FY19 | 40.4% | −46.3% |
|---|
| FY18 | 48.7% | −49.6% |
|---|
| FY17 | 46.7% | −45.9% |
|---|
| FY16 | - | −36% |
|---|